{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:1666"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:1666","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"An investigation of the regulation of BLIMP1 by the epstein-barr virus in B cells","abstract":"BLIMP1 is a transcription factor that regulates plasma cell differentiation. In this thesis I explore the regulation of BLIMP1 by EBV and by the EBV oncogene, latent membrane protein-1 (LMP1). In chapter 3, I show that BLIMP1α is down-regulated following the infection of germinal centre (GC) B cells with EBV. I also show that the ectopic expression of LMP1, was sufficient to decrease BLIMP1α expression in these cells and was accompanied by a partial disruption of the BLIMP1α transcriptional programme, including the aberrant induction of C-MYC. In chapter 4, I show that the ectopic expression of BLIMP1α in EBV-transformed cells and in EBV-positive Burkitt’s lymphoma cells can induce the viral lytic cycle. Chapter 5 provides evidence that LMP1 drives a reciprocal regulatory loop in GC B cells involving BLIMP1α and C-MYC which ultimately leads to the activation of C-MYC and the repression of BLIMP1α. Finally, in chapter 6, I present preliminary evidence showing that the BLIMP1β isoform is up-regulated in EBV-transformed B cells and in Hodgkin’s lymphoma cells; an effect which appeared to be mediated by hypomethylation of the BLIMP1β specific promoter. In summary, my results suggest that EBV can subvert normal B cell differentiation by modulating expression of the different BLIMP1 isoforms. These effects appear to be important not only for the regulation of the viral lytic cycle in B cells, but also potentially for the block in differentiation characteristic of EBV-associated B cell lymphomas.","abstract_html":"BLIMP1 is a transcription factor that regulates plasma cell differentiation. In this thesis I explore the regulation of BLIMP1 by EBV and by the EBV oncogene, latent membrane protein-1 (LMP1). In chapter 3, I show that BLIMP1α is down-regulated following the infection of germinal centre (GC) B cells with EBV. I also show that the ectopic expression of LMP1, was sufficient to decrease BLIMP1α expression in these cells and was accompanied by a partial disruption of the BLIMP1α transcriptional programme, including the aberrant induction of C-MYC. In chapter 4, I show that the ectopic expression of BLIMP1α in EBV-transformed cells and in EBV-positive Burkitt’s lymphoma cells can induce the viral lytic cycle. Chapter 5 provides evidence that LMP1 drives a reciprocal regulatory loop in GC B cells involving BLIMP1α and C-MYC which ultimately leads to the activation of C-MYC and the repression of BLIMP1α. Finally, in chapter 6, I present preliminary evidence showing that the BLIMP1β isoform is up-regulated in EBV-transformed B cells and in Hodgkin’s lymphoma cells; an effect which appeared to be mediated by hypomethylation of the BLIMP1β specific promoter. In summary, my results suggest that EBV can subvert normal B cell differentiation by modulating expression of the different BLIMP1 isoforms. These effects appear to be important not only for the regulation of the viral lytic cycle in B cells, but also potentially for the block in differentiation characteristic of EBV-associated B cell lymphomas.","abstract_has_math":false,"creators":["Vrzalikova, Katerina"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-07","date_published":"2011-07","updated_at":"2026-11-19T09:26:45Z","subjects":["R Medicine (General)","RC Internal medicine","RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/1666/1/Vrzalikova11PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A1666","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["bloodwise"]},{"key":"dc:creator","label":"Author","values":["Vrzalikova, Katerina"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2011-07"]},{"key":"dc:date.issued","label":"Date","values":["2011-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Cancer Studies"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/1666/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["R Medicine (General)","RC Internal medicine","RC0254 Neoplasms. Tumors. Oncology (including Cancer)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/1666/1/Vrzalikova11PhD.pdf","http://etheses.bham.ac.uk//id/eprint/1666/2/Decl_IS_Vrzalikova11PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["BLIMP1 is a transcription factor that regulates plasma cell differentiation. In this thesis I explore the regulation of BLIMP1 by EBV and by the EBV oncogene, latent membrane protein-1 (LMP1). In chapter 3, I show that BLIMP1α is down-regulated following the infection of germinal centre (GC) B cells with EBV. I also show that the ectopic expression of LMP1, was sufficient to decrease BLIMP1α expression in these cells and was accompanied by a partial disruption of the BLIMP1α transcriptional programme, including the aberrant induction of C-MYC. In chapter 4, I show that the ectopic expression of BLIMP1α in EBV-transformed cells and in EBV-positive Burkitt’s lymphoma cells can induce the viral lytic cycle. Chapter 5 provides evidence that LMP1 drives a reciprocal regulatory loop in GC B cells involving BLIMP1α and C-MYC which ultimately leads to the activation of C-MYC and the repression of BLIMP1α. Finally, in chapter 6, I present preliminary evidence showing that the BLIMP1β isoform is up-regulated in EBV-transformed B cells and in Hodgkin’s lymphoma cells; an effect which appeared to be mediated by hypomethylation of the BLIMP1β specific promoter. In summary, my results suggest that EBV can subvert normal B cell differentiation by modulating expression of the different BLIMP1 isoforms. These effects appear to be important not only for the regulation of the viral lytic cycle in B cells, but also potentially for the block in differentiation characteristic of EBV-associated B cell lymphomas."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["An investigation of the regulation of BLIMP1 by the epstein-barr virus in B cells"]}]}],"canonical_facts":{"dc:contributor.sponsor":["bloodwise"],"dc:creator":["Vrzalikova, Katerina"],"dc:date":["2011-07"],"dc:date.issued":["2011-07"],"dc:description.abstract":["BLIMP1 is a transcription factor that regulates plasma cell differentiation. In this thesis I explore the regulation of BLIMP1 by EBV and by the EBV oncogene, latent membrane protein-1 (LMP1). In chapter 3, I show that BLIMP1α is down-regulated following the infection of germinal centre (GC) B cells with EBV. I also show that the ectopic expression of LMP1, was sufficient to decrease BLIMP1α expression in these cells and was accompanied by a partial disruption of the BLIMP1α transcriptional programme, including the aberrant induction of C-MYC. In chapter 4, I show that the ectopic expression of BLIMP1α in EBV-transformed cells and in EBV-positive Burkitt’s lymphoma cells can induce the viral lytic cycle. Chapter 5 provides evidence that LMP1 drives a reciprocal regulatory loop in GC B cells involving BLIMP1α and C-MYC which ultimately leads to the activation of C-MYC and the repression of BLIMP1α. Finally, in chapter 6, I present preliminary evidence showing that the BLIMP1β isoform is up-regulated in EBV-transformed B cells and in Hodgkin’s lymphoma cells; an effect which appeared to be mediated by hypomethylation of the BLIMP1β specific promoter. In summary, my results suggest that EBV can subvert normal B cell differentiation by modulating expression of the different BLIMP1 isoforms. These effects appear to be important not only for the regulation of the viral lytic cycle in B cells, but also potentially for the block in differentiation characteristic of EBV-associated B cell lymphomas."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/1666/1/Vrzalikova11PhD.pdf","http://etheses.bham.ac.uk//id/eprint/1666/2/Decl_IS_Vrzalikova11PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Cancer Studies"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/1666/"],"dc:subject":["R Medicine (General)","RC Internal medicine","RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"dcterms:accessrights":["public","staffonly"],"dc:title":["An investigation of the regulation of BLIMP1 by the epstein-barr virus in B cells"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:26:45Z"}